Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG‐CoA Reductase
Open accessThe DOI matches its Crossref record.
Abstract
Hyperlipidaemia, i.e. increase in total cholesterol and triglycerides, is a common side‐effect of the immunosuppressive drugs rapamycin (RAPA) and cyclosporine A (CsA), and is probably related to inhibition of the 27‐hydroxylation of cholesterol (acid pathway of bile acid biosynthesis). This might be one of the causes for the increase in plasma cholesterol, as 27‐hydroxycholesterol is a potent suppressor of 3‐hydroxy‐3‐methyl‐glutaryl‐CoA reductase (HMGR), a key enzyme of cholesterol synthesis. As the sterol 27‐hydroxylase (CYP27A1) inhibition by CsA is well known, we evaluated the effect of another immunosuppressive drug, RAPA, on this enzyme in HepG2 mitochondria, which confirmed the dose‐dependent inhibition of mitochondrial CYP27A1 by cyclosporine (10–20 µM), while the inhibition by RAPA required a higher dose (50–100 µM). Corresponding K i was 10 µM for CsA (non‐competitive inhibition) and 110 µM for RAPA (competitive inhibition). Cotreatment with both immunosuppressive drugs showed an additive inhibitory effect on CYP27A1 activity. Later, we analysed the effect of these immunosuppressants on HMGR expression in HepG2 cells, and a dose‐dependent up‐regulation of HMGR gene expression was observed. The results suggest that RAPA and CsA are both inhibitors of CYP27A1 activity with slightly different mechanisms and that they may accordingly increase HMGR expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Jennen, D. G. J., Magkoufopoulou, C., Ketelslegers, H. B., van Herwijnen, M. H. M., Kleinjans, J. C. S., & van Delft, J. H. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq026 · Cited by 220
Metabolic consequences of modern immunosuppressive agents in solid organ transplantation
Bamgbola, O. (2016) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816641580 · Cited by 85
“com 119 LDL cholesterol to oxidative milieu [Gueguen et al. 2007].”
BackgroundFunctional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis
Charles, K. N., Shackelford, J. E., Faust, P. L., Fliesler, S. J., Stangl, H., & Kovacs, W. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.560266 · Cited by 36
“The mTOR inhibitor rapamycin has been shown to have opposing effects on SREBP-2 processing and the expression of HMGCR in different cell types (Gueguen et al., 2007; Sharpe and Brown, 2008; Ma et al., 2010).”
Background
Metadata
- Authors
- Gueguen, Y., Ferrari, L., Souidi, M., Batt, A., Lutton, C., Siest, G., & Visvikis, S.
- Venue
- Basic & Clinical Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 2007-04-17
- Volume
- 100
- Issue
- 6
- Pages
- 392-397
- ISSN
- 1742-7835 (ISSN-L)
- 1742-7843
- OpenAlex
- W2028827955
- Cited by
- 41
- References
- 0
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG‐CoA Reductase. https://app.cochat.ai/papers/10.1111/j.1742-7843.2007.00066.x
- The paper
- Gueguen, Y., Ferrari, L., Souidi, M., Batt, A., Lutton, C., Siest, G., & Visvikis, S. (2007). Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG‐CoA Reductase. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/j.1742-7843.2007.00066.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.